Avai Bio (AVAI) Accounts Payables (2019 - 2026)

Avai Bio (AVAI) has 8 years of Accounts Payables data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 79.93% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 79.93% YoY), and the FY2026 full-year result was $1.6 million, up 79.93% from the prior year.
• Accounts Payables advanced to $1.6 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.6 million in Q1 2026 to a low of $1986.0 in Q1 2022.
• A 5-year average of $776773.5 and a median of $885267.0 in 2025 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 99.27% in 2022 and jumped 11828.55% in 2023, its largest moves.
• Tracing AVAI's Accounts Payables over 5 years: stood at $87001.0 in 2022, then jumped by 877.0% to $850000.0 in 2023, then soared by 84.11% to $1.6 million in 2024, then decreased by 10.58% to $1.4 million in 2025, then increased by 13.83% to $1.6 million in 2026.
• Business Quant data shows AVAI's Accounts Payables at $1.6 million in Q1 2026, $1.4 million in Q4 2025, and $1.2 million in Q3 2025.